FDA Inspection
Rentschler Biopharma Inc.Rentschler Biopharma Inc. – FDA Inspection, Mar 26, 2018
Record Details
This FDA Inspection record concerns Rentschler Biopharma Inc., with an inspection on March 26, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- People
- Alice C. Silva (Issuing Officer)
- Arie Menachem (Issuing Officer)
- Justin A. Boyd (Investigator)
View Company Profile
ID · b20fd2e8-f6c5-4b7f-b897-73d82dc0902f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1046134
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Rentschler Biopharma Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| December 10, 2025 | Not classified | New England District Office | |
| January 17, 2025 | Not classified | New England District Office | |
| March 24, 2023 | Not classified | New England District Office | |
| December 13, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 23, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Rentschler Biopharma Inc.
- FDA Inspection 1298478 - 2025-12-10
- FDA Inspection 1259307 - 2025-01-17
- FDA Inspection 1202865 - 2023-03-24
- FDA Inspection 1116307 - 2019-12-13
- FDA Inspection 961189 - 2016-02-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.